Thursday 22 October 2020
Home      All news      Contact us      RSS     
medicalxpress - 7 days ago

Immunotherapy combo halts rare, stage 4 sarcoma in teen

A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment, had a rapid and complete response to a novel combination of immunotherapy, according to new research published by a team of scientists from John Theurer Cancer Center at Hackensack University Medical Center and the Georgetown Lombardi Comprehensive Cancer Center, both of whom are part of the Georgetown Lombardi Comprehensive Cancer Center Consortium.


Latest News
Hashtags:   

Immunotherapy

 | 

combo

 | 

halts

 | 

stage

 | 

sarcoma

 | 

Sources